VAERS Explorer
Back to explore

Report #2824523

Received Feb 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Dec 24, 2024
Onset
Dec 24, 2024
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKX026668—

Symptoms (1)

Product storage error

Symptom narrative

No additional AE; HCP called and reported inadvertent administration of GARDASIL 9 to a patient after a temperature excursion that occurred on 02DEC2024. Vaccine was administered after the excursion on 24DEC2024.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Patient's concurrent conditions, pertinent medical history and concomitant therapies were not provided. On 24-DEC-2024, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot #X026668, expiration date: 10-APR-2026, administered for prophylaxis (strength, route of administration, and anatomical location were not provided) that underwent a temperature excursion that occurred on 02-DEC-2024. The temperature excursion was 46.7 degrees Fahrenheit for the time frame of 192 hours. There was no previous temperature excursion. No adverse event.